28 Feb 2011 07:00
28 February 2011
Akers biosciences, inc
(the "company")
Total Voting Rights
For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the Company announces that as at 28 February the total number of common shares of no par value in issue is 168,715,666, with each share carrying the right to one vote.
The Company has no common shares held in treasury. The total number of voting rights in the Company is therefore 168,715,666. This figure of 168,715,666 common shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
Contact details
Akers Biosciences Thomas A. Nicolette, President and Chief Executive Officer
| Tel: + 1 856 848 8698 |
Daniel Stewart & Company plc (Nomad and Broker) Antony Legge/Noélle Greenaway
| Tel: + 44 (0) 20 7776 6550 |
M: Communications Ben Simons | Tel: + 44 (0) 20 7920 2340
|
AKR.L (AKR)